Glioblastoma cancers national cancer institute u s. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Neoplastic Stem Cells Cell Line, Tumor Tumor Cells, Cultured HT29 Cells

Organisms2

Mice, Nude Mice, SCID

Diseases49

Glioblastoma Neoplasms Brain Neoplasms Breast Neoplasms Lung Neoplasms Prostatic Neoplasms Ovarian Neoplasms Neoplasm Invasiveness Colonic Neoplasms Neoplasm Recurrence, Local Neoplasm Metastasis Stomach Neoplasms Colorectal Neoplasms Disease Progression Pancreatic Neoplasms Glioma Carcinoma, Non-Small-Cell Lung Carcinoma Uterine Cervical Neoplasms Genetic Predisposition to Disease Urinary Bladder Neoplasms Neoplasms, Second Primary Adenocarcinoma Carcinoma, Squamous Cell Rectal Neoplasms Skin Neoplasms Carcinoma, Small Cell Melanoma Kidney Neoplasms Astrocytoma Head and Neck Neoplasms Neoplasms, Experimental Liver Neoplasms Genital Neoplasms, Female Gastrointestinal Neoplasms Neoplasms, Radiation-Induced Neutropenia Bone Neoplasms Thyroid Neoplasms Cell Transformation, Neoplastic Neovascularization, Pathologic Endometrial Neoplasms Central Nervous System Neoplasms Esophageal Neoplasms Nausea Leukemia, Lymphocytic, Chronic, B-Cell Vomiting Lymphoma, Non-Hodgkin Neoplasms, Ductal, Lobular, and Medullary

Chemicals and Drugs43

Antineoplastic Agents Dacarbazine Antineoplastic Agents, Alkylating Tumor Markers, Biological Cisplatin Neoplasm Proteins Paclitaxel Cancer Vaccines Fluorouracil Antineoplastic Agents, Phytogenic Deoxycytidine RNA, Messenger Prostate-Specific Antigen Organoplatinum Compounds Antimetabolites, Antineoplastic DNA, Neoplasm Receptors, Estrogen Receptor, Epidermal Growth Factor Tumor Suppressor Protein p53 Tamoxifen Antibodies, Monoclonal, Humanized Antibodies, Monoclonal RNA, Small Interfering Carcinogens Quinazolines Camptothecin Taxoids Receptor, erbB-2 Antineoplastic Agents, Hormonal Cyclophosphamide Receptors, Progesterone Vinblastine Anticarcinogenic Agents Carboplatin Protein Kinase Inhibitors Tumor Suppressor Proteins Antigens, Neoplasm Topotecan Enzyme Inhibitors DNA Modification Methylases Antibiotics, Antineoplastic Proto-Oncogene Proteins MicroRNAs

Analytical, Diagnostic and Therapeutic Techniques and Equipment79

SEER Program Early Detection of Cancer Drug Screening Assays, Antitumor Clinical Trials as Topic Survival Rate Survival Analysis Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Prognosis Registries Retrospective Studies Incidence Combined Modality Therapy Neoplasm Staging Follow-Up Studies Disease-Free Survival Risk Factors Drug Administration Schedule Risk Assessment Prospective Studies Xenograft Model Antitumor Assays Kaplan-Meier Estimate Risk Radiotherapy Chemotherapy, Adjuvant Gene Expression Profiling Clinical Trials, Phase III as Topic Research Design Questionnaires Multicenter Studies as Topic Reproducibility of Results Odds Ratio Cohort Studies Multivariate Analysis Logistic Models Mammography Infusions, Intravenous Sensitivity and Specificity Reverse Transcriptase Polymerase Chain Reaction Patient Selection Neoplasm Transplantation Clinical Trials, Phase II as Topic Radiotherapy, Adjuvant Oligonucleotide Array Sequence Analysis Transplantation, Heterologous Neoplasm Grading Clinical Trials, Phase I as Topic Carcinogenicity Tests Maximum Tolerated Dose Neoplasms, Experimental Blotting, Western Radiotherapy Dosage Confidence Intervals Predictive Value of Tests Polymerase Chain Reaction Drug Evaluation, Preclinical Administration, Oral Mass Screening Immunohistochemistry Prevalence Mastectomy Mastectomy, Segmental Lymph Node Excision Epidemiologic Studies Flow Cytometry Tumor Burden Models, Biological Pilot Projects Regression Analysis Feasibility Studies Probability Biopsy Cross-Sectional Studies Data Collection Immunotherapy Models, Statistical Transfection Drug Evaluation Mastectomy, Simple

Psychiatry and Psychology2

Smoking Cooperative Behavior

Phenomena and Processes28

Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Risk Dose-Response Relationship, Drug Time Factors Genetic Predisposition to Disease Odds Ratio Mutation Cell Proliferation Apoptosis Sensitivity and Specificity Cell Survival Maximum Tolerated Dose Diet Genotype Cell Cycle Cell Movement Cell Division DNA Methylation Cell Growth Processes Down-Regulation Probability Signal Transduction Postmenopause RNA Interference Transfection Microsatellite Repeats Algorithms

Disciplines and Occupations7

Medical Oncology Biomedical Research Research Design Research Immunohistochemistry Translational Medical Research Radiation Oncology

Anthropology, Education, Sociology and Social Phenomena10

National Cancer Institute (U.S.)National Institutes of Health (U.S.)National Institute for Occupational Safety and Health (U.S.)Government Programs Quality of Life National Heart, Lung, and Blood Institute (U.S.)Age Distribution Forecasting Community Networks Health Education

Humanities1

Quality of Life

Information Science14

SEER Program Survival Rate Registries Incidence Databases, Factual Questionnaires Information Services Databases as Topic Prevalence Community Networks Internet Data Collection Online Systems Algorithms

Named Groups7

European Continental Ancestry Group Survivors African Americans Research Personnel Ethnic Groups Hispanic Americans African Continental Ancestry Group

Health Care68

National Cancer Institute (U.S.)National Institutes of Health (U.S.)Academies and Institutes SEER Program Clinical Trials as Topic Survival Rate Survival Analysis Cancer Care Facilities Treatment Outcome Research Support as Topic Registries Retrospective Studies Incidence Follow-Up Studies Disease-Free Survival Age Factors Risk Factors American Cancer Society Risk Assessment Prospective Studies Kaplan-Meier Estimate Risk National Institute for Occupational Safety and Health (U.S.)Clinical Trials, Phase III as Topic Institute of Medicine (U.S.)Questionnaires Tissue Banks Multicenter Studies as Topic Pharmacy and Therapeutics Committee Reproducibility of Results Odds Ratio Cohort Studies Multivariate Analysis Logistic Models Sensitivity and Specificity Patient Selection Sex Factors Clinical Trials, Phase II as Topic National Heart, Lung, and Blood Institute (U.S.)National Health Programs Clinical Trials, Phase I as Topic Age Distribution Congresses as Topic Confidence Intervals Predictive Value of Tests Financing, Government Mass Screening Ethnic Groups Confounding Factors (Epidemiology)Professional Staff Committees Prevalence Epidemiologic Studies Community Networks Health Education Practice Guidelines as Topic Pilot Projects Regression Analysis Feasibility Studies Probability Health Planning Guidelines Cross-Sectional Studies Occupational Exposure Data Collection Health Services Accessibility International Agencies Cost-Benefit Analysis Models, Statistical Healthcare Disparities

Geographicals4

United States Canada Egypt Delaware

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Glioblastoma National Cancer Institute (U.S.)Neoplastic Stem Cells National Institutes of Health (U.S.)United States Neoplasms Brain Neoplasms Academies and Institutes SEER Program Antineoplastic Agents Breast Neoplasms Early Detection of Cancer Drug Screening Assays, Antitumor Clinical Trials as Topic Survival Rate Medical Oncology Lung Neoplasms Survival Analysis Cancer Care Facilities Antineoplastic Combined Chemotherapy Protocols Prostatic Neoplasms Treatment Outcome Research Support as Topic Cell Line, Tumor Ovarian Neoplasms Prognosis Registries Retrospective Studies Incidence Combined Modality Therapy Dacarbazine Neoplasm Staging Follow-Up Studies Neoplasm Invasiveness Disease-Free Survival Gene Expression Regulation, Neoplastic Colonic Neoplasms Mice, Nude Neoplasm Recurrence, Local Age Factors Neoplasm Metastasis Stomach Neoplasms Antineoplastic Agents, Alkylating Biomedical Research Tumor Markers, Biological Colorectal Neoplasms Risk Factors Drug Resistance, Neoplasm American Cancer Society Drug Administration Schedule Disease Progression Risk Assessment Canada Prospective Studies Pancreatic Neoplasms Xenograft Model Antitumor Assays Cisplatin Kaplan-Meier Estimate Glioma Risk Radiotherapy Tumor Cells, Cultured Databases, Factual Neoplasm Proteins Chemotherapy, Adjuvant Dose-Response Relationship, Drug Carcinoma, Non-Small-Cell Lung Carcinoma National Institute for Occupational Safety and Health (U.S.)Gene Expression Profiling Clinical Trials, Phase III as Topic Time Factors Uterine Cervical Neoplasms Research Design Genetic Predisposition to Disease Paclitaxel Institute of Medicine (U.S.)Urinary Bladder Neoplasms Government Programs Neoplasms, Second Primary Adenocarcinoma Questionnaires Tissue Banks Multicenter Studies as Topic Cancer Vaccines European Continental Ancestry Group Survivors Fluorouracil Pharmacy and Therapeutics Committee Quality of Life Reproducibility of Results Antineoplastic Agents, Phytogenic Odds Ratio Carcinoma, Squamous Cell Smoking Cohort Studies Mutation Multivariate Analysis Deoxycytidine Logistic Models

No FAQ available that match "glioblastoma cancers national cancer institute u s"